Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 242 USD -0.12% Market Closed
Market Cap: 39.7B USD

Veeva Systems Inc
PP&E Gross

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Veeva Systems Inc
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Veeva Systems Inc
NYSE:VEEV
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
PP&E Gross
$115.6m
CAGR 3-Years
76%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
PP&E Gross
$22.5m
CAGR 3-Years
33%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
PP&E Gross
$145.7m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
16%
Certara Inc
NASDAQ:CERT
PP&E Gross
$16m
CAGR 3-Years
1%
CAGR 5-Years
28%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
PP&E Gross
$57.6m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veeva Systems Inc
Glance View

Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.

VEEV Intrinsic Value
161.41 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

Back to Top